celecoxib 25 MG/ML Oral Solution [Elyxyb]

Verify with CMS →

celecoxib

RxCUI: 2373460

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
0.2%
Plan Coverage
11
Plans Covering
T3
Avg Tier
50%
Prior Auth Required

What the CMS Formulary Data Shows for celecoxib 25 MG/ML Oral Solution [Elyxyb]

Per the CMS 2026 Part D formulary file, celecoxib 25 MG/ML Oral Solution [Elyxyb] (RxNorm concept RXCUI 2373460, generic name celecoxib) appears on 2 distinct formulary files spanning 11 Medicare Part D plan offerings - 0.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 4, with a cross-plan average of Tier 3.

Real-world access to celecoxib 25 MG/ML Oral Solution [Elyxyb] depends on utilization management as much as tier placement: 50% of covering formularies require prior authorization. 0% require step therapy. 50% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,627,703 Part D beneficiaries filled celecoxib 25 MG/ML Oral Solution [Elyxyb] in 2023, with total plan-and-beneficiary spending of $198,046,988 and an average per-beneficiary annual cost of $121.67. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry celecoxib 25 MG/ML Oral Solution [Elyxyb] today.

Coverage Details

Formularies covering
2
Plans covering
11
Coverage rate
0.2%
Tier range
Tier 2 – Tier 4
Average tier
Tier 3, Preferred Brand

Restrictions

Prior authorization required
50% of formularies
Step therapy required
0% of formularies
Quantity limits
50% of formularies

2023 Medicare Spending

Beneficiaries
1,627,703
Total spending
$198,046,988
Avg per beneficiary
$121.67

Tier Distribution Across Plans

1 plans
Tier 2, Generic
10 plans
Tier 4, Non-Preferred

Medicare Advantage Plans (MA-PD) Covering celecoxib 25 MG/ML Oral Solution [Elyxyb]

11 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
CalOptima Health OneCare Complete (HMO D-SNP) ORANGE COUNTY HEALTH AUTHORITY T2 Yes $0 CA
Health First Rewards H1099-014 (HMO) HEALTH FIRST HEALTH PLANS T4 No $0 FL
Health First SunSaver H1099-016 (HMO) HEALTH FIRST HEALTH PLANS T4 No $0 FL
Health First Complete Care H1099-023 (HMO) HEALTH FIRST HEALTH PLANS T4 No $0 FL
Health First Emerald Plus H1099-024 (HMO) HEALTH FIRST HEALTH PLANS T4 No $0 FL
Health First Premier Access H1099-025 (HMO-POS) HEALTH FIRST HEALTH PLANS T4 No $0 FL
Health First Emerald Plus H1099-026 (HMO) HEALTH FIRST HEALTH PLANS T4 No $0 FL
Health First Premier Access H1099-027 (HMO-POS) HEALTH FIRST HEALTH PLANS T4 No $0 FL
Health First Emerald Plus H1099-028 (HMO) HEALTH FIRST HEALTH PLANS T4 No $0 FL
Health First Value H1099-006 (HMO) HEALTH FIRST HEALTH PLANS T4 No $15.00 FL
Health First Classic H1099-001 (HMO-POS) HEALTH FIRST HEALTH PLANS T4 No $49.40 FL

Frequently Asked Questions

Is celecoxib 25 MG/ML Oral Solution [Elyxyb] covered by Medicare Part D?

Yes, celecoxib 25 MG/ML Oral Solution [Elyxyb] is covered by 11 Medicare Part D plans (0.2% of all Part D formularies).

What tier is celecoxib 25 MG/ML Oral Solution [Elyxyb] on Medicare Part D plans?

celecoxib 25 MG/ML Oral Solution [Elyxyb] averages Tier 3 across Part D plans, ranging from Tier 2 to Tier 4.

Does celecoxib 25 MG/ML Oral Solution [Elyxyb] require prior authorization?

50% of Part D formularies require prior authorization for celecoxib 25 MG/ML Oral Solution [Elyxyb]. Step therapy: 0%. Quantity limits: 50%.

How much does Medicare spend on celecoxib 25 MG/ML Oral Solution [Elyxyb]?

In 2023, total Medicare Part D spending on celecoxib 25 MG/ML Oral Solution [Elyxyb] was $198,046,988, covering 1,627,703 beneficiaries. The average spend per beneficiary was $121.67.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial